Company Filing History:
Years Active: 2020
Title: Lotta Jansson: Innovating in Thyroid Disease Research
Introduction
Lotta Jansson is a distinguished inventor based in Diepenbeek, Belgium. She has made significant contributions to the field of medical research, particularly in understanding and treating thyroid diseases. With her innovative work, she has been able to enhance knowledge regarding the thyroid stimulating hormone receptor.
Latest Patents
Lotta Jansson holds one patent titled "Thyroid stimulating hormone receptor peptides and uses thereof." This invention provides a composition that includes specific peptides of the Thyroid Stimulating Hormone Receptor (TSHR). The patented peptides include the amino acid sequence KKKKYVSIDVTLQQLESHKKK (SEQ ID NO: 1) and GLKMFPDLTKVYSTD (SEQ ID NO: 2), or variants with at least 60% sequence identity. Importantly, the application of this composition is aimed at preventing or suppressing the formation of activating autoantibodies in Graves' disease, a significant autoimmune disorder affecting thyroid function.
Career Highlights
Lotta Jansson plays an integral role at Apitope International NV, a company known for advancing therapeutic solutions in autoimmune diseases. Her research and innovative approach have positioned her as a vital contributor in the industry, helping to bring forth novel treatments that can potentially change lives.
Collaborations
Throughout her career, Lotta has collaborated with prominent researchers including Keith Martin and David Wraith. Their combined efforts reflect a commitment to exploring the complexities of thyroid diseases and the potential for impactful therapeutic interventions.
Conclusion
Lotta Jansson's work exemplifies the spirit of innovation in the medical field. Through her patent and collaborations, she continues to pave the way for advancements in thyroid disease treatment. Her contributions not only enhance scientific understanding but also hold the promise of improving patient outcomes in the realm of autoimmune disorders.